about
Perinatal asphyxia induced neuronal loss by apoptosis in the neonatal rat striatum: a combined TUNEL and stereological study.Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson's Disease.Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's diseaseNitric Oxide Production in the Striatum and Cerebellum of a Rat Model of Preterm Global Perinatal Asphyxia.Longterm quiescent cells in the aged human subventricular neurogenic system specifically express GFAP-delta.Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links.Therapeutic potential of autophagy-enhancing agents in Parkinson's disease.LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies.Topographic mapping between basal forebrain cholinergic neurons and the medial prefrontal cortex in mice.Cognitive correlates of visual hallucinations in non-demented Parkinson's disease patients.Impact of perinatal asphyxia on the GABAergic and locomotor system.Prenatal stress and neonatal rat brain development.Regional differences in gene expression and promoter usage in aged human brains.Origin of α-mannosidase activity in CSF.Pedunculopontine cholinergic cell loss in hallucinating Parkinson disease patients but not in dementia with Lewy bodies patients.Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease.A non-cholinergic neuronal loss in the pedunculopontine nucleus of toxin-evoked parkinsonian rats.Developmental apoptosis in the spinal cord white matter in neonatal rats.Morphometric changes in the cortical microvascular network in Alzheimer's disease.A comprehensive analysis of SNCA-related genetic risk in sporadic parkinson diseaseThe proliferative capacity of the subventricular zone is maintained in the parkinsonian brainUse of cryostat sections from snap-frozen nervous tissue for combining stereological estimates with histological, cellular, or molecular analyses on adjacent sectionsα-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodiesCerebral Corpora amylacea are dense membranous labyrinths containing structurally preserved cell organellesCharacterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy BodiesAuthor Correction: Prefrontal cortical ChAT-VIP interneurons provide local excitation by cholinergic synaptic transmission and control attentionTranscriptomic signatures of brain regional vulnerability to Parkinson's diseasePrefrontal cortical ChAT-VIP interneurons provide local excitation by cholinergic synaptic transmission and control attentionPath mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levelsNeuropathological and genetic characteristics of a post-mortem series of cases with dementia with Lewy bodies clinically suspected of Creutzfeldt-Jakob's diseaseLewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes
P50
Q31040263-3218876C-E239-413C-AE64-E295E0416A41Q35621190-1E6D6B1D-EDAA-4E05-9819-CBA30CCC2332Q35667600-13F045D7-9B4E-4EC9-9DDA-9487368B0B04Q36245278-BF9FF134-6F7D-4D7C-8BD0-8F0AC774C061Q37714572-E4C33366-2572-408B-A03E-40591B334AADQ38346779-F82DF814-2ABF-4D7F-BFB7-228BA1B043F0Q38753762-3C3DF3A2-EBAA-4C59-8502-8D1115C947C7Q38765856-510B7D8C-6929-4A77-9D37-7F9E31A816A4Q39136594-A47732CB-BA5D-4691-9792-8B38E18086B4Q42177729-9374A6DF-F8F2-49A5-8C29-0856D7214081Q43966924-88A63768-41E2-410D-99B0-97669B0B636AQ44328313-21C24828-C6AA-4682-B3B3-ED0F7CD6DE49Q46768568-6AF4091F-9310-4B9F-AE81-9D1FB4CDDCB7Q48154845-3A981C2F-2D99-4B68-A5DA-9A75B24565CFQ48237927-005F2B09-CBFB-41B2-B028-C3DA65607528Q48874432-0D072313-AE71-4AF0-A574-0CAC4DDEFAD1Q50563223-A4848210-DB5B-4BFC-A07B-6FE149C5924AQ50905556-F4DB3602-9C9F-4348-9A5F-B9E115AA4A2FQ52126478-54ED6891-E234-4C2C-82C1-988199DF0087Q53313027-612BE981-99F5-461A-8963-ADF15391A02AQ57177625-D95ADF59-6E7C-4D45-8AC9-4608A1299B4DQ57277135-08859E3B-0D3D-4D0A-B8D9-869510D57914Q57805577-F9D28251-D3FE-468E-8B26-04B3975395FFQ59901049-CC6BB3C0-BB2A-49DD-9A38-E218898C0616Q60300434-EFE7C671-EB2F-4C48-B0A5-E187721CCB3CQ89287825-DEA6E9A1-EE40-498B-AD37-4705F784BBBFQ89531852-5BF6675D-3D97-46E4-B401-899C16FBA774Q90091679-282B02E5-7680-484C-B7DE-9E2CED1FA0C4Q91386067-9C9F1A9C-A173-4F1A-BFDD-B1C3B1166300Q91592968-51172156-6467-48DB-8454-6A8E55A5A816Q91687410-ADEDA670-E1C4-4F50-8EB1-C6146D5B2A81Q93001087-882C6FCB-1290-4D1C-850E-1A597D43EE9A
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Wilma van de Berg
@ast
Wilma van de Berg
@en
Wilma van de Berg
@es
Wilma van de Berg
@nl
type
label
Wilma van de Berg
@ast
Wilma van de Berg
@en
Wilma van de Berg
@es
Wilma van de Berg
@nl
prefLabel
Wilma van de Berg
@ast
Wilma van de Berg
@en
Wilma van de Berg
@es
Wilma van de Berg
@nl
P106
P1153
6603310899
P31
P496
0000-0002-6175-5357